Shanafelt Armen Insider Trades

Insider Trading History

Track insider trading activity for Shanafelt Armen. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Surface Oncology
Surface Oncology SURF
Director
Holding Value $25.7k 24,000 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.2k 24,000 shares
$2.01
$1.07
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $3.37M 43,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$78.48
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $516k 43,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.57M 86,000 shares
$18.25
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $1.8M 150,000 shares
Last Trade
Dec 13, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.38M 14,685 shares
$94.25
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $1.63M 135,315 shares
Last Trade
Dec 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.26M 13,516 shares
$93.00
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $1.46M 121,799 shares
Last Trade
Dec 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11M 121,799 shares
$90.50
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $480k 40,000 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.8M 40,000 shares
$170.00
$12.01
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $18.9k 17,700 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136k 17,700 shares
$7.69
$1.07
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $12.8k 12,000 shares
Last Trade
Jun 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.2k 12,000 shares
$4.35
$1.07
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $337k 28,100 shares
Last Trade
Jun 08, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.25M 28,100 shares
$222.25
$12.01
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $17.7k 16,531 shares
Last Trade
Oct 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.3k 16,531 shares
$1.17
$1.07
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $7.42k 6,937 shares
Last Trade
Jul 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.4k 6,937 shares
$2.79
$1.07
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $149k 12,400 shares
Last Trade
Jun 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.96M 12,400 shares
$158.25
$12.01
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $12.9k 12,100 shares
Last Trade
Jun 05, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.6k 12,100 shares
$3.69
$1.07
Aileron Therapeutics
Aileron Therapeutics ALRN
Director
Holding Value $21.1k 10,000 shares
Last Trade
Jun 21, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 10,000 shares
$120.40
$2.11
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
10% owner
Holding Value $221k 18,400 shares
Last Trade
Jun 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.73M 18,400 shares
$257.00
$12.01
Protagonist Therapeutics
Protagonist Therapeutics PTGX
10% owner
Holding Value $1.23M 12,000 shares
Last Trade
May 29, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.8k 12,000 shares
$6.98
$102.79
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $0 0 shares
Last Trade
Apr 23, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$90.2M 7,000,000 shares
$12.88
$1.07
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $3.69M 3,447,817 shares
Last Trade
Apr 23, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.43M 266,000 shares
$12.88
$1.07
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $3.4M 3,181,817 shares
Last Trade
Apr 23, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$41M 3,181,817 shares
$12.88
$1.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up